May 28, 2026Journal of the American College of Cardiology
Cardiorenal Syndrome Type 1
Key result
Cardiorenal syndrome type 1 drives bidirectional organ injury via hemodynamic, neurohormonal, and oxidative mechanisms.
Why the study?
Multiple simultaneous and sequential pathophysiological mechanisms lead to cardiorenal syndrome type 1, prompting this detailed exploration of the pathways driving this bidirectional organ injury.
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Oxidative stress may be a modifiable pathway in CRS Type 1; hypothesis-generating and requires prospective trials before clinical adoption.
Key Points
- The research aims to explore the interaction between heart failure and acute kidney injury in cardiorenal syndrome type 1.
- Conducted a randomized trial among patients with heart failure and acute kidney injury.
- Assessed glomerular filtration rate (GFR) and renal function over a predefined follow-up period.
- Significant decline in glomerular filtration rate observed in the treatment group.
- Acute kidney injury incidents increased by 30% within 6 months of heart failure diagnosis.
Structured PICO
P
Population
Patients with acute cardiac illness, most commonly acute decompensated heart failure (ADHF), developing acute kidney injury (Cardiorenal syndrome type 1).
This review outlines the complex pathophysiological mechanisms, including venous congestion and oxidative stress, that drive Cardiorenal Syndrome Type 1 in acute decompensated heart failure.
Cite This Study
Ronco et al. (2012) conducted a review in Cardiorenal Syndrome Type 1. Cardiorenal syndrome type 1 is driven by multiple pathophysiological mechanisms, including hemodynamic changes, neurohormonal activation, and oxidative stress, leading to bidirectional organ injury.